The Drug Regulators of the European Union have said that it has discovered a ‘possible connection’ between the Astrona gene (AstraZeneca) anti-Corona virus vaccine and the problem of blood clot in the blood.
In Australia, on Thursday, people under the age of 50 have been recommended not to give a dose of the anti-COVID-19 vaccine AstraZeneca. The announcement was made following a series of emergency meetings of the Drug Regulators of Australia during the day. Significantly, the European Medicine Agency said that it had found a possible contact between the vaccine and the clotting of the rare blood clots.
Prime Minister Scott Morrison said that he had received various advice in this regard from the advisory group. The most prominent advice among these is that people under 50 years of age should be given Pfizer vaccines. The Australian Technical Advisory Group related to vaccination recommends that people under the age of 50 who have taken the first dose of the AstraZeneca vaccine should be given a second dose as medical advice indicates that cases of clotting in the blood are only the first dose. Have been revealed only after being taken.
The group said that the first vaccine of AstraZeneca should be given to someone under 50 years of age only when it is clear that there is no danger of applying it. On the other hand, the health authorities of the Philippines have decided to temporarily stop the introduction of AstraZeneca vaccine to people below 60 years of age. This decision has been taken after the news of blood clotting has come.
Spain has also imposed a ban
The European Medicine Agency had predicted this on Wednesday. However, he did not specify any age limit for vaccinating adults. Officials of the Department of Health and the Food and Drug Administration (FDA) have said that experts are reviewing information related to the side effects caused by the AstraZeneca vaccine. In the Philippines, vaccines are being developed by Synovac Biotech based in AstraZeneca and China to protect against COVID-19. Spain has also decided to limit the use of AstraZeneca vaccine only to elderly people in the fight against the Corona virus.
‘Possible contact’ in blood clots and vaccine
The EU drug regulator has said that it has found a “possible connection” between AstraZeneca’s anti-Corona virus vaccine and the problem of rare blood clots. However it also said that the benefits of this vaccine are still more than the risks. The European Medicines Agency (EMA), in a statement released on Wednesday, did not announce any new restrictions on the use of vaccines for people 18 years and older.
Also read: World News Bulletin: Myanmar coup fire reaches UK, stops ambassador from entering office, read five big news of the world
Also read: Pope appeals to IMF and World Bank for poor countries, ‘reduce debt burden and increase stake in decision-making’